In addition, SCLC tumors with TP53 wild-type or RB1 wild-type presented a statistically significant correlation with a low tumor mutational burden status, whereas SCLC tumors with both wild-type TP53 and RB1 displayed the lowest tumor mutational burden status. This evidence concerns the gene RB1 and neoplasm.